Twitter-2102775149443379364

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2026-09-23
Post ID
2102775149443379364

What do two-year outcomes look like after concomitant epicardial surgical ablation during CABG?

A multicenter analysis of 537 patients from the TRAC-AF Registry found:​​
- 94% and 89% survival at 12 and 24 months, respectively​.
- 85% and 77% freedom from atrial arrhythmias at

Post image URL
https://pbs.twimg.com/media/HS6O2tOWkAATJL7.jpg
Post URL
https://t.co/5Ss3MwgvJ1
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:share:7508540836276576256

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1790175637
Post ID
urn:li:share:7508540836276576256

What do two-year outcomes look like after concomitant epicardial surgical ablation during CABG?

A multicenter analysis of 537 patients from the TRAC-AF Registry found:​​
- 94% and 89% survival at 12 and 24 months, respectively​.
- 85% and 77% freedom from atrial arrhythmias at 12 and 24 months, respectively.​

Read more about the findings here: <a href="https://okt.to/QKExLU&quot; target="_blank">https://okt.to/QKExLU</a&gt;

Post image URL
https://media.licdn.com/dms/image/v2/D4E10AQHzezVFarEj5Q/image-shrink_800/B4EaDOyGC9HcAg-/0/1790175633933?e=1791133200&v=beta&t=C5a-IwNrgkGnNhgJaJmrf6M38J3s6XxTPs4n25NngDs
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7508540836276576256
Post creted timestamp

Twitter-2102080548625678747

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2026-09-21
Post ID
2102080548625678747

The EnCompass clamp utilizes Synergy technology to provide real-time, adaptive energy delivery – precisely to the specific tissue between the jaws.

The result: discrete, reproducible lesions that stand the test of time. Learn more:

Post URL
https://t.co/d07Adxw17F
Post creted timestamp

Twitter-2102080542078275929

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2026-09-21
Post ID
2102080542078275929

Robust. Transmural. Contiguous.

That's what a successful ablation requires and what the Isolator® Synergy™ EnCompass® clamp was built to deliver.

<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a> <a href="https://twitter.com/hashtag/SurgicalAblation?src=hashtag_click&quot; target="_blank">#SurgicalAblation</a>

Post video URL
https://video.twimg.com/ext_tw_video/2102080520158887936/pu/vid/avc1/320x400/cH3po77eQWyjG6U-.mp4?tag=12
Post URL
https://t.co/vMlaNXxqC3
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:ugcPost:7507847048382144513

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1790010225
Post ID
urn:li:ugcPost:7507847048382144513

Robust. Transmural. Contiguous.

That's what a successful ablation requires and what the Isolator® Synergy™ EnCompass® clamp was built to deliver.

The EnCompass clamp utilizes Synergy technology to provide real-time, adaptive energy delivery – precisely to the specific tissue between the jaws.

The result: discrete, reproducible lesions that stand the test of time.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=SurgicalAblation&highli…; target='_blank'>#SurgicalAblation</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

Post video URL
https://dms.licdn.com/playlist/vid/v2/D4E10AQFU1Lgy9se64g/mp4-720p-30fp-crf28/B4EaDE69kVIEBo-/0/1790010188922?e=1791126000&v=beta&t=jfufg7uXk8_fJu09j4uRK5-sh7xnA5GQjtWAnlaA-FM
Post URL
https://www.linkedin.com/feed/update/urn:li:ugcPost:7507847048382144513
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:share:7507453610772037632

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1789916422
Post ID
urn:li:share:7507453610772037632

AtriCure is growing our Regulatory Affairs and Scientific Affairs teams.

We’re hiring for Regulatory Affairs Specialist and Senior Principal Publications Specialist roles—opportunities for professionals with experience in regulatory submissions, clinical evidence, scientific publications, and medical writing.

Know someone who could be a great fit? We’d love to connect.

Explore open opportunities: <a href="https://okt.to/WjLnHe&quot; target="_blank">https://okt.to/WjLnHe</a&gt;

Post image URL
https://media.licdn.com/dms/image/v2/D4E10AQHbkxhsMkok1Q/image-shrink_800/B4EaC_VROuKIAk-/0/1789916419437?e=1790960400&v=beta&t=jvZrC3YnGGGgcnqmK8rgExcWgKppw88-iI9AxMMNPbY
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7507453610772037632
Post creted timestamp

Twitter-2101049159486702035

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2026-09-18
Post ID
2101049159486702035

Discover a streamlined approach to left atrial appendage exclusion and epicardial ablation during CABG with the AtriClip FLEX-Mini® device and Isolator® Synergy™ EnCompass® clamp.

Stop by the AtriCure booth at the STS CABG Academy to learn more.

More information:

Post image URL
https://pbs.twimg.com/media/HShtEWkW0AA0O6i.jpg
Post URL
https://t.co/96IGNoPhBa
Post creted timestamp

Twitter-2100963160320528591

Submitted by ryadav-admin on
Feed type
Twitter
Post created date
2026-09-18
Post ID
2100963160320528591

Decades of evidence. Continuous innovation. One commitment to advancing LAA exclusion.

From development and testing to refinement and design, evidence has shaped the evolution of the AtriClip portfolio. Learn more:
<a href="https://t.co/qbsqHPx63V&quot; target="_blank">https://t.co/qbsqHPx63V</a&gt;

<a href="https://twitter.com/hashtag/AtriClip?src=hashtag_click&quot; target="_blank">#AtriClip</a> <a href="https://twitter.com/hashtag/LAAExclusion?src=hashtag_click&quot; target="_blank">#LAAExclusion</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Post image URL
https://pbs.twimg.com/media/HSge226XUAAXNEK.jpg
Post URL
https://t.co/T4LVoJdRSB
Post creted timestamp

LinkedIn-USA,ASIA,CANADA-urn:li:share:7506728889839357952

Submitted by ryadav-admin on
Feed type
Linkedin
Post created date
1789743635
Post ID
urn:li:share:7506728889839357952

Decades of evidence. Continuous innovation. One commitment to advancing LAA exclusion.

From development and testing to refinement and design, evidence has shaped the evolution of the AtriClip portfolio.

<a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAExclusion&highlighte…; target='_blank'>#LAAExclusion</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

Post image URL
https://media.licdn.com/dms/image/v2/D4E10AQHAliZNURwquw/image-shrink_800/B4EaC1CIi3K8Ag-/0/1789743630975?e=1790780400&v=beta&t=6vM4HjiREBooygqEireHq4hPZobIXgPaNN6rJyR_JZc
Post URL
https://www.linkedin.com/feed/update/urn:li:share:7506728889839357952
Post creted timestamp
Subscribe to
© 2026 Atricure, Inc. All Rights Reserved.